Hyperkalemia complicating digoxin toxicity in a patient with renal failure.

[1]  R. Cody,et al.  Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. , 1983, The American journal of medicine.

[2]  R. Weinshilboum,et al.  Aging and aldosterone. , 1983, The American journal of medicine.

[3]  E. Haber,et al.  Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. , 1982, The New England journal of medicine.

[4]  G Levy,et al.  Gastrointestinal clearance of drugs with activated charcoal. , 1982, The New England journal of medicine.

[5]  J. Rowe,et al.  Adrenergic modulation of extrarenal potassium disposal. , 1980, The New England journal of medicine.

[6]  M. Davidson,et al.  Influence of epinephrine and propranolol on transmembrane K transfer in anuric dogs with hyperkalemia. , 1979, The Journal of pharmacology and experimental therapeutics.

[7]  F. Finkelstein,et al.  Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis. , 1975, The American journal of medicine.

[8]  K. Shine,et al.  Massive intravenous digoxin overdosage. , 1974, The New England journal of medicine.

[9]  T. Smith.  Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition. , 1972, The Journal of clinical investigation.

[10]  Westervelt Fb.  Insulin effect in uremia. , 1969 .

[11]  B. Lown,et al.  Digitalis, electrolytes and the surgical patient. , 1960, The American journal of cardiology.